CST3 and cancer: Of note, most studies evaluating the non-GFR determinants of cystatin C did not include patients with cancer,19,21 and the incidence of factors such as thyroid dysfunction and corticosteroid exposure in patients with cancer is not well known and likely varies throughout cancer treatment.